Abk Biomedical USA, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$286Kgeneral payments (2019-2025)
$200Kresearch payments (2019-2025)
69clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Mark Westcott | New York, NY | Diagnostic Radiology | $103,116.51 |
| Robert Lewandowski | Chicago, IL | Vascular & Interventional Radiology | $31,162.77 |
| Steven Citron | Atlanta, GA | Vascular & Interventional Radiology | $25,726.52 |
| Eric Wang | Charlotte, NC | Diagnostic Radiology | $23,451.23 |
| Rahul Patel | New York, NY | Vascular & Interventional Radiology | $20,866.61 |
| Suvranu Ganguli | Boston, MA | Vascular & Interventional Radiology | $20,055.92 |
| Ripal Gandhi | Miami, FL | Vascular & Interventional Radiology | $15,174.38 |
| Fred Moeslein | Columbus, OH | Vascular & Interventional Radiology | $12,337.73 |
| Jeremy Kim | Charlotte, NC | Vascular & Interventional Radiology | $7,877.71 |
| Charles Nutting | Greenwood Village, CO | Vascular & Interventional Radiology | $7,184.53 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.